September 18, 2022
Video

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

04:57

Yazan Daaboul and Jonas Lanz discuss Three-Year Outcomes of the Randomized SCOPE I Trial at TCT 2022

Partner Content

Explore All